Ledipasvir-Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection.
Vasily A IsakovNatalia GankinaViacheslav MorozovKathryn KerseySophia LuAnu OsinusiEvguenia SvarovskaiaDiana M BrainardRiina SalupereElena Orlova-MorozovaKonstantin ZhdanovPublished in: Clinical drug investigation (2018)
Non-cirrhotic, treatment-naive patients with genotype 1 HCV mono-infection and HCV/HIV-1 co-infection achieved high rates of SVR12 with 8 weeks of treatment with ledipasvir/sofosbuvir. ClinicalTrials.gov identifier: NCT02472886.